Reported Jul 1, 2020 · Ongoing

amneal Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, Rx only, 100 Tablets bottles, Manufactured by:…

Amneal Pharmaceuticals of New York, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Amneal Pharmaceuticals of New York, LLC · 50 Horseblock Rd · Brookhaven, NY · 11719-9509

Is this the product you have?

  • amneal Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, Rx only, 100 Tablets bottles
  • Manufactured byAmneal Pharmaceuticals Pvt. Ltd. Ahmedabad, 388213
  • INDIA Distributed byAmneal Pharmaceuticals LLC Bridgewater, NJ 08807 NDC 65162-179-10
Lot codes and dates
  • 112 of 112 codes

    • AM181337A
    • 10/31/2020
    • AM181338A
    • 10/31/2020
    • AM181339A
    • 11/30/2020
    • AM181340A
    • 11/30/2020
    • AM181341A
    • 11/30/2020
    • AM181342A
    • 11/30/2020
    • AM181343A
    • 11/30/2020
    • AM181344A
    • 11/30/2020
    • AM181356A
    • 11/30/2020
    • AM181357A
    • 11/30/2020
    • AM181358A
    • 11/30/2020
    • AM181359A
    • 11/30/2020
    • AM181360A
    • 11/30/2020
    • AM181361A
    • 11/30/2020
    • AM181362A
    • 11/30/2020
    • AM181363A
    • 11/30/2020
    • AM181415A
    • 11/30/2020
    • AM190040B
    • 12/31/2020
    • AM190041A
    • 12/31/2020
    • AM190042A
    • 12/31/2020
    • AM190043A
    • 12/31/2020
    • AM190044A
    • 12/31/2020
    • AM190045A
    • 12/31/2020
    • AM190046A
    • 12/31/2020
    • AM190473B
    • 4/30/2021
    • AM190474A
    • 4/30/2021
    • AM190475A
    • 4/30/2021
    • AM190476A
    • 4/30/2021
    • AM190477A
    • 4/30/2021
    • AM190478A
    • 4/30/2021
Amount recalled
N/A

This recall covers 12 products

The agency filed one notice per product. You are reading one of them; the other 11 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Amneal Pharmaceuticals recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 5:04 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.